Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER. [electronic resource]
Producer: 20110211Description: 2237-46 p. digitalISSN:- 1499-2752
- Adalimumab
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- diagnostic imaging
- Arthrography
- Disease Progression
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Joints -- physiopathology
- Male
- Methotrexate -- administration & dosage
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.